Rosen Law Firm Scrutinizes Disc Medicine Over Misleading Information
Investors who suffered losses in Disc Medicine, Inc. are being urged to join a potential securities class action investigation. New York-based Rosen Law Firm is evaluating claims that the company disseminated materially misleading business information, following a regulatory setback that triggered a sharp decline in the firm’s stock price.






















